Related Experiment Videos
Adverse cutaneous reactions to antidepressants.
1Department of Psychiatry, Washington University School of Medicine, St. Louis.
The American Journal of Psychiatry
|April 1, 1988
Summary
Adverse cutaneous reactions, or rashes, affect 2-4% of patients on antidepressant medications, with some drugs causing more frequent skin reactions. Management strategies for these antidepressant-induced rashes are discussed.
Area of Science:
- Dermatology
- Pharmacology
- Psychiatry
Background:
- Antidepressant medications are widely prescribed.
- Adverse cutaneous reactions are a known side effect of many drugs.
- Understanding these reactions is crucial for patient safety and treatment adherence.
Purpose of the Study:
- To review the literature on adverse cutaneous reactions to antidepressant medications.
- To summarize the prevalence, clinical patterns, and pathogenesis of these reactions.
- To provide recommendations for managing patients experiencing these side effects.
Main Methods:
- Literature review of studies on antidepressant-induced cutaneous reactions.
- Analysis of reported prevalence rates.
- Categorization of morphologic patterns and discussion of pathogenetic mechanisms.
Main Results:
- The prevalence of antidepressant-induced rashes ranges from 2% to 4%, with higher rates for specific agents like maprotiline and carbamazepine.
- The majority of cutaneous reactions present as exanthematous eruptions.
- Morphologic patterns are consistent regardless of whether the reaction is immunologic or non-immunologic.
Conclusions:
- Adverse cutaneous reactions are an important consideration in antidepressant therapy.
- Awareness of prevalence and patterns aids in diagnosis and management.
- Effective management strategies can mitigate the impact of these reactions on patients.